ERBB2 and breast cancer: Thereby, clinical emphasis is directed at the molecular classification of BC subtypes, namely luminal A, luminal B, human epidermal growth factor receptor 2 (HER2) enriched and basal like, each exhibiting their own prognostic implications (see Table 1) [5].